Cellcept: Clinical Trials

2 trials of Cellcept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 21Unknown 1

Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NK Cells in Cord Blood Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Fludarabine Phosphate - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 1UnknownM.D. Anderson Cancer Center132013-05-032020-02-11
Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
CD4+CD25+CD127lowFoxP3+ T regulatory cells injection, Alemtuzumab, Mycophenolate mofetil - End-Stage Renal Disease, Kidney Failure
Phase 1 / Phase 2UnknownPirogov Russian National Research Medical University302011-10-012011-11-18

Conditions studied

Hodgkin Disease (1)  ·  Kidney Failure, Chronic (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Renal Insufficiency (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Pirogov Russian National Research Medical University (1)

Countries

Russia (1)  ·  United States (1)

Top investigators

Chitra Hosing (1)  ·  Michael M. Kaabak, M.D. Ph.D. (1)  ·  Svetlana N. Bykovskaia, M.D. Ph.D. (1)

NIH funding

P30CA016672 (1)